BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26243671)

  • 1. Are clear cell carcinomas of the ovary and endometrium phenotypically identical? A proteomic analysis.
    Fata CR; Seeley EH; Desouki MM; Du L; Gwin K; Hanley KZ; Hecht JL; Jarboe EA; Liang SX; Parkash V; Quick CM; Zheng W; Shyr Y; Caprioli RM; Fadare O
    Hum Pathol; 2015 Oct; 46(10):1427-36. PubMed ID: 26243671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic and Immunohistochemical Study of Clear Cell Carcinoma of the Uterine Endometrium and Cervix in Comparison to Ovarian Clear Cell Carcinoma.
    Ju B; Wang J; Yang B; Sun L; Guo Y; Hao Q; Wu J
    Int J Gynecol Pathol; 2018 Jul; 37(4):388-396. PubMed ID: 28796747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
    Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
    Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should endometrial clear cell carcinoma be classified as Type II endometrial carcinoma?
    Bae HS; Kim H; Young Kwon S; Kim KR; Song JY; Kim I
    Int J Gynecol Pathol; 2015 Jan; 34(1):74-84. PubMed ID: 25473756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classifications of ovarian cancer tissues by proteomic patterns.
    Zhu Y; Wu R; Sangha N; Yoo C; Cho KR; Shedden KA; Katabuchi H; Lubman DM
    Proteomics; 2006 Nov; 6(21):5846-56. PubMed ID: 17068758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined mRNA microarray and proteomic analysis of eutopic endometrium of women with and without endometriosis.
    Fassbender A; Verbeeck N; Börnigen D; Kyama CM; Bokor A; Vodolazkaia A; Peeraer K; Tomassetti C; Meuleman C; Gevaert O; Van de Plas R; Ojeda F; De Moor B; Moreau Y; Waelkens E; D'Hooghe TM
    Hum Reprod; 2012 Jul; 27(7):2020-9. PubMed ID: 22556377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
    Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH
    Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging the clear cell renal cell carcinoma proteome.
    Morgan TM; Seeley EH; Fadare O; Caprioli RM; Clark PE
    J Urol; 2013 Mar; 189(3):1097-103. PubMed ID: 23009866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells.
    Kao YC; Lin MC; Lin WC; Jeng YM; Mao TL
    Histopathology; 2012 Nov; 61(5):760-8. PubMed ID: 22747504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
    Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
    J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
    Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ
    Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Accuracy of Alpha-Methylacyl-CoA Racemase Immunohistochemical Expression for the Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas.
    Nili F; Fathi S; Tavakoli M; Mirzaian E; Lotfi M
    Iran J Pathol; 2023; 18(1):57-63. PubMed ID: 37383161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular proteomics imaging of tumor interfaces by mass spectrometry.
    Kang S; Shim HS; Lee JS; Kim DS; Kim HY; Hong SH; Kim PS; Yoon JH; Cho NH
    J Proteome Res; 2010 Feb; 9(2):1157-64. PubMed ID: 19821573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of clear cell renal cell carcinoma. Identification of potential tumor markers.
    Sun CY; Zang YC; San YX; Sun W; Zhang L
    Saudi Med J; 2010 May; 31(5):525-32. PubMed ID: 20464042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis reflects different histologic subtypes of epithelial ovarian cancer.
    Jia L; Zhang H; Qu X; Deng B; Kong B
    Med Hypotheses; 2012 Mar; 78(3):407-9. PubMed ID: 22227042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precursors of endometrial clear cell carcinoma.
    Fadare O; Liang SX; Ulukus EC; Chambers SK; Zheng W
    Am J Surg Pathol; 2006 Dec; 30(12):1519-30. PubMed ID: 17122507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein- versus peptide fractionation in the first dimension of two-dimensional high-performance liquid chromatography-matrix-assisted laser desorption/ionization tandem mass spectrometry for qualitative proteome analysis of tissue samples.
    Melchior K; Tholey A; Heisel S; Keller A; Lenhof HP; Meese E; Huber CG
    J Chromatogr A; 2010 Oct; 1217(40):6159-68. PubMed ID: 20810122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analyses of serous and endometrioid epithelial ovarian cancers - cases studies - molecular insights of a possible histological etiology of serous ovarian cancer.
    Longuespée R; Gagnon H; Boyon C; Strupat K; Dauly C; Kerdraon O; Ighodaro A; Desmons A; Dupuis J; Wisztorski M; Vinatier D; Fournier I; Day R; Salzet M
    Proteomics Clin Appl; 2013 Jun; 7(5-6):337-54. PubMed ID: 23589350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma.
    Morita A; Miyagi E; Yasumitsu H; Kawasaki H; Hirano H; Hirahara F
    Proteomics; 2006 Nov; 6(21):5880-90. PubMed ID: 17022098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.